Higher odds of irritable bowel syndrome among hospitalized patients using cannabis: a propensity-matched analysis. Issue 7 (July 2019)
- Record Type:
- Journal Article
- Title:
- Higher odds of irritable bowel syndrome among hospitalized patients using cannabis: a propensity-matched analysis. Issue 7 (July 2019)
- Main Title:
- Higher odds of irritable bowel syndrome among hospitalized patients using cannabis
- Authors:
- Adejumo, Adeyinka C.
Ajayi, Tokunbo O.
Adegbala, Oluwole M.
Bukong, Terence N. - Abstract:
- Abstract : Background: The endogenous cannabinoid system modulates many brain–gut and gut–brain physiologic pathways, which are postulated to be dysfunctional in irritable bowel syndrome (IBS). Herein, we examine the relationship between cannabis use disorder (CUD) and having IBS. Patients and methods: After selecting patients aged 18 years and above from the 2014 Nationwide Inpatient Survey, we used the International Classification of Diseases, 9th ed. codes to identify individuals with CUD, IBS, and the established risk factors for IBS. We then estimated the crude and adjusted odds ratios of having a diagnosis of IBS with CUD and assessed for the interactions of CUD with other risk factors (SAS 9.4). We confirmed our findings in two ways: conducting a similar analysis on a previous Nationwide Inpatient Survey data (2012); and using a greedy algorithm to design a propensity-scored case–control (1 : 10) study, approximating a pseudorandomized clinical trial. Results: Out of 4 709 043 patients evaluated, 0.03% had a primary admission for IBS and 1.32% had CUD. CUD was associated with increased odds of IBS [adjusted odds ratio: 2.03; 95% confidence interval (CI): 1.53–2.71]. CUD was related to higher odds for IBS among males compared with females (3.48; 1.98–6.12 vs. 1.48; 0.88–2.50), and Hispanics and Caucasians compared with Blacks (5.28; 1.77–15.76, 1.80; 1.02–3.18 vs. 1.80; 0.65–5.03). On propensity-matching, CUD was associated with 80% increased odds for IBS (1.82;Abstract : Background: The endogenous cannabinoid system modulates many brain–gut and gut–brain physiologic pathways, which are postulated to be dysfunctional in irritable bowel syndrome (IBS). Herein, we examine the relationship between cannabis use disorder (CUD) and having IBS. Patients and methods: After selecting patients aged 18 years and above from the 2014 Nationwide Inpatient Survey, we used the International Classification of Diseases, 9th ed. codes to identify individuals with CUD, IBS, and the established risk factors for IBS. We then estimated the crude and adjusted odds ratios of having a diagnosis of IBS with CUD and assessed for the interactions of CUD with other risk factors (SAS 9.4). We confirmed our findings in two ways: conducting a similar analysis on a previous Nationwide Inpatient Survey data (2012); and using a greedy algorithm to design a propensity-scored case–control (1 : 10) study, approximating a pseudorandomized clinical trial. Results: Out of 4 709 043 patients evaluated, 0.03% had a primary admission for IBS and 1.32% had CUD. CUD was associated with increased odds of IBS [adjusted odds ratio: 2.03; 95% confidence interval (CI): 1.53–2.71]. CUD was related to higher odds for IBS among males compared with females (3.48; 1.98–6.12 vs. 1.48; 0.88–2.50), and Hispanics and Caucasians compared with Blacks (5.28; 1.77–15.76, 1.80; 1.02–3.18 vs. 1.80; 0.65–5.03). On propensity-matching, CUD was associated with 80% increased odds for IBS (1.82; 1.27–2.60). Conclusion: Our findings suggest that CUD is significantly associated with IBS among the general population. Males, Caucasians, and Hispanics might be more impacted by CUD associated IBS. Additional biomedical studies are required to elucidate this relationship. Abstract : Supplemental Digital Content is available in the text. … (more)
- Is Part Of:
- European journal of gastroenterology & hepatology. Volume 31:Issue 7(2019)
- Journal:
- European journal of gastroenterology & hepatology
- Issue:
- Volume 31:Issue 7(2019)
- Issue Display:
- Volume 31, Issue 7 (2019)
- Year:
- 2019
- Volume:
- 31
- Issue:
- 7
- Issue Sort Value:
- 2019-0031-0007-0000
- Page Start:
- Page End:
- Publication Date:
- 2019-07
- Subjects:
- cannabis -- endocannabinoid -- epidemiology -- marijuana -- neuroscience -- risk factors
Digestive organs -- Diseases -- Periodicals
Liver -- Diseases -- Periodicals
Digestive organs -- Diseases
Liver -- Diseases
Periodicals
616.33 - Journal URLs:
- http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=toc&D=yrovft&AN=00042737-000000000-00000 ↗
http://www.eurojgh.com/ ↗
http://journals.lww.com/pages/default.aspx ↗ - DOI:
- 10.1097/MEG.0000000000001382 ↗
- Languages:
- English
- ISSNs:
- 0954-691X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.729400
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 13062.xml